American Association for Cancer Research

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Scheinberg
    Scheinberg
  3. Mcdevitt
    Mcdevitt
  4. Rosales
    Rosales
  5. Arcila
    Arcila
  6. Ladanyi
    Ladanyi
  7. Park
    Park
  8. Tallman
    Tallman
  9. Abdel-Wahab
    Abdel-Wahab
  10. Berger
    Berger

Groups

  1. Adult Leukemia (152)
  2. Center for Hematologic Malignancies (152)
  3. Department of Medicine (132)
  4. Hematologic Malignancies, Division of (131)
  5. GSK Faculty (99)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (78)
  7. Tow Center for Developmental Oncology (TCDO) (59)
  8. Hematologic Malignancies Research (57)
  9. Sloan Kettering Institute Faculty (49)
  10. Molecular Pharmacology and Chemistry Program Faculty (46)
Search Within
  1. "Adult Leukemia"
Formats
  1. Meeting Abstract (82)
  2. Journal Article (65)
  3. Conference Paper (2)
  4. Correspondence (1)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Adult Leukemia (152)
  2. Center for Hematologic Malignancies (152)
  3. Department of Medicine (132)
  4. Hematologic Malignancies, Division of (131)
  5. GSK Faculty (99)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (78)

More Groups

People
  1. Ross Levine (40)
  2. David Scheinberg (34)
  3. Dharmarao Thapi (23)
  4. David Spriggs (21)
  5. Renier Brentjens (18)
  6. Michael Mcdevitt (12)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (4)
  4. 2022 (11)
  5. 2021 (8)
  6. 2020 (8)

More Years

Publications
  1. Cancer Research (86)
  2. Clinical Cancer Research (66)

Results (152)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of FHD-286, a dual BRG1/BRM (SMARCA4/SMARCA2) inhibitor, in patients with advanced myeloid malignancies
    Journal Article

    DiNardo, C. D.; Fathi, A. T.; Kishtagari, A.; Bhalla, K. N.; Quintás-Cardama, A.; Reilly, S. A.; Almon, C.; Patriquin, C.; Nabhan, S.; Healy, K.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
    Journal Article

    Yin, Y.; Xu, H.; He, L.; Brown, J. R.; Mato, A. R.; Aittokallio, T.; Skånland, S. S.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable
    Journal Article

    Codilupi, T.; Szybinski, J.; Arunasalam, S.; Jungius, S.; Dunbar, A. C.; Stivala, S.; Brkic, S.; Albrecht, C.; Vokalova, L.; Yang, J. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Project confirm: Accelerated drug approvals for CML—Response
    Correspondence

    Sweet, K. L.; Cortes, J. E.; Apperley, J. F.; Mann, M.; Mauro, M. J.; Oehler, V. G.; Ruiz, C.; Schiffer, C. A.; Ehrlich, L. A.; Pamuk, G. E.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase Ib trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
    Journal Article

    Mascarenhas, J.; Migliaccio, A. R.; Kosiorek, H.; Bhave, R.; Palmer, J.; Kuykendall, A.; Mesa, R.; Rampal, R. K.; Gerds, A. T.; Yacoub, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Project confirm: Accelerated drug approvals for chronic myeloid leukemia
    Editorial

    Sweet, K. L.; Cortes, J. E.; Apperley, J. F.; Mann, M.; Mauro, M. J.; Oehler, V. G.; Ruiz, C.; Schiffer, C. A.; Ehrlich, L. A.; Pamuk, G. E.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Crizotinib has preclinical efficacy in Philadelphia-negative myeloproliferative neoplasms
    Journal Article

    Gurska, L. M.; Okabe, R.; Schurer, A.; Tong, M. M.; Soto, M.; Choi, D.; Ames, K.; Glushakow-Smith, S.; Montoya, A.; Tein, E.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A phase I/II open-label study of molibresib for the treatment of relapsed/refractory hematologic malignancies
    Journal Article

    Dawson, M. A.; Borthakur, G.; Huntly, B. J. P.; Karadimitris, A.; Alegre, A.; Chaidos, A.; Vogl, D. T.; Pollyea, D. A.; Davies, F. E.; Morgan, G. J.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of parsaclisib-ruxolitinib combination therapy in myelofibrosis patients (Pts) with low vs higher baseline platelet count (PC): A subgroup analysis of data from a phase 2 study
    Meeting Abstract

    Yacoub, A.; Borate, U.; Rampal, R.; Ali, H.; Wang, E.; Gerds, A.; Hobbs, G.; Kremyanskaya, M.; Winton, E.; O'Connell, C.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: